Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists seek to standardize NAD+ measurement in healthy volunteers

NCT ID NCT07416786

First seen Feb 24, 2026 · Last updated May 23, 2026 · Updated 10 times

Summary

This study aims to improve how NAD+ levels are measured in healthy adults. Researchers will give participants a common over-the-counter supplement called nicotinamide riboside and then use MRI scans, blood tests, and urine tests to track changes. The goal is to make NAD+ measurements more reliable for future clinical studies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY ADULTS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Penn Medicine

    Philadelphia, Pennsylvania, 19104-6006, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

Conditions

Explore the condition pages connected to this study.